Addiction Research

According to the World Health Organization (WHO), addiction is 'a chronic disease of the central nervous system that is characterized by a loss of control over impulsive behavior that leads to compulsive drug seeking and taking, and to relapses even after months of abstinence'. Addiction is a complex neuroadaptive process, where drugs of abuse alter cellular and molecular aspects of neural function. The brain circuits mediating the various behavioral effects of these drugs are rendered more, or less, responsive to those effects.

Addiction Research Products Targets

Products for Addiction Research - Page 34

  1. Cat.No. Product Name Information/Activity
  2. BCC5784 pep2-SVKI 328944-75-8 pep2-SVKI chemical structure
  3. BCC7135 IEM 1460 121034-89-7 IEM 1460 chemical structure
  4. BCC5049 IEM 1754 dihydrobroMide IEM 1754 2HBr is a selective AMPA/kainate receptor blockers for GluR1 and GluR3 with IC50 of 6 μM. IEM 1754 dihydrobroMide chemical structure
  5. BCC6909 1-BCP 1-BCP (Piperonylic acid piperidide) is a centrally active drug that modulates AMPA receptor gated currents. 1-BCP is a memory-enhancing agent. 1-BCP chemical structure
  6. BCC6868 Diazoxide Diazoxide (Sch-6783) is an ATP-sensitive potassium channel activator, has the potential for hyperinsulinism treatment. Diazoxide chemical structure
  7. BCC5785 pep2-SVKE 1315378-76-7 pep2-SVKE chemical structure
  8. BCC5783 pep4c 243843-43-8 pep4c chemical structure
  9. BCC4824 Piracetam Piracetam (UCB-6215) is a cyclic derivative of the neurotransmitter gamma-aminobutyric acid (GABA), used in treatment of a wide range of cognitive disorders. Piracetam chemical structure
  10. BCC6940 ATPA ATPA is a selective glutamate receptor GluR5 activator with EC50s of 0.66, 9.5, 1.4, 23, 32, 18, and 14 μM for GluR5wt, GluR5(S741M), GluR5(S721T), GluR5(S721T, S741M), GluR5(S741A), GluR5(S741L), and GluR5(S741V), respectively. ATPA chemical structure
  11. BCC6586 Domoic acid 14277-97-5 Domoic acid chemical structure

Items 331 to 340 of 509 total